Replies to post #43807 on Relief Therapeutics Holding AG (RLFTF)

[theswordman]

ZYESAMI® (aviptadil) is the sole remaining investigational medicine in ACTIV-3b with recent closures of other arms

https://www.nrxpharma.com/nrx-pharmaceuticals-announces-us-national-institutes-of-health-study-of-zyesami-aviptadil-in-critical-covid-19-is-cleared-to-complete-full-enrollment/